Evoq Remedies Ltd - Submission Of Revised Unaudited Financial Results For The Half Year Ended On 30Th September, 2022 Along With Limited Review Report

In reference to captioned subject and pursuant to Regulation 33(3) (d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are hereby submitting the Revised Unaudited Financial Results for the Half Year ended on 30th September, 2022 along with Limited Review Report. Kindly take this revised result on your record and oblige us. Thanking You. Yours Faithfully,